Advanced Search
Advanced Search Results
Search results for diagnosing bribery risk
Click here to go to the Global Anti-Bribery Guidance website. Corporate Political Engagement 2018: Rating Private Sector Political Transparency (November 2018) Incentivising Ethics: Managing Incentives to Encourage Good and Deter Bad Behaviour (October 2016) Managing Third Party R
The Transparency International Corporate Anti-Corruption Benchmark is a comprehensive tool that measures and compares the performance of anti-corruption programmes across companies. The methodology is based on Transparency International’s extensive anti-corruption expertise and understanding of best practice for the private sector, combined with input from experiences specialist in-house
Corruption within the pharmaceutical and healthcare sectors is a matter of life and death. It has a corrosive impact on health, negatively impacting public health budgets, the price of health services and medicines, and ultimately the quality of care dispensed. Reports estimate that as much as 6% of annual global health expenditure is lost to corruption
In the past few days, we have seen two high-profile corruption stories emanating from China – the allegations against GlaxoSmithKline (GSK) and the indictment of high-profile regional governor Bo Xilai. What should we make of them?
